Evoq Remedies Ltd

Evoq Remedies Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Evoq Remedies Ltd

₹ 2.52 9.57%
01 Apr - close price
evoqremedies.com BSE - SME: 543500
About

Incorporated in 2010, EVOQ Remedies Ltd is in the pharmaceutical business.[1]

Key Points

Business Overview:[1]
EVOQRL deals in the trading of the pharma
products and commission agent in pharma products, etc.

Website BSE
  • Market Cap ₹ 6.28 Cr.
  • Current Price ₹ 2.52
  • High / Low ₹ 6.11 / 2.30
  • Stock P/E 3.57
  • Book Value ₹ 17.9
  • Dividend Yield 0.00 %
  • ROCE 0.35 %
  • ROE 0.26 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is trading at 0.14 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 5.33% over past five years.
  • Promoter holding is low: 11.2%
  • Company has a low return on equity of 2.57% over last 3 years.
  • Contingent liabilities of Rs.6.55 Cr.
  • Earnings include an other income of Rs.3.46 Cr.
  • Company has high debtors of 268 days.
  • Promoter holding has decreased over last 3 years: -62.3%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Services Services Commercial Services & Supplies Trading & Distributors

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Mar 2021 Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025
2.76 4.93 11.85 15.79 4.60 3.90 0.15 0.00 11.76 25.51
1.71 4.20 11.12 15.48 8.64 3.83 1.87 1.63 12.36 26.46
Operating Profit 1.05 0.73 0.73 0.31 -4.04 0.07 -1.72 -1.63 -0.60 -0.95
OPM % 38.04% 14.81% 6.16% 1.96% -87.83% 1.79% -1,146.67% -5.10% -3.72%
0.00 0.00 0.00 0.00 6.02 0.00 2.26 0.01 2.40 1.06
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.03
Profit before tax 1.05 0.73 0.73 0.31 1.98 0.07 0.54 -1.62 1.76 0.08
Tax % 22.86% 0.00% 50.68% 0.00% 33.84% 28.57% 29.63% 0.00% 2.27% 25.00%
0.81 0.73 0.36 0.31 1.31 0.05 0.38 -1.62 1.71 0.05
EPS in Rs 810.00 730.00 0.26 0.23 0.96 0.04 0.28 -0.65 0.69 0.02
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
3.25 9.07 10.02 16.78 20.39 4.05 11.76 37.27
3.23 9.07 9.07 15.32 24.12 5.69 13.99 38.82
Operating Profit 0.02 0.00 0.95 1.46 -3.73 -1.64 -2.23 -1.55
OPM % 0.62% 0.00% 9.48% 8.70% -18.29% -40.49% -18.96% -4.16%
0.00 0.00 0.00 0.00 6.02 2.26 2.41 3.46
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.01 0.05 0.07
Profit before tax 0.02 0.00 0.95 1.46 2.29 0.61 0.13 1.84
Tax % 0.00% 25.26% 25.34% 29.26% 26.23% 30.77%
0.01 0.00 0.72 1.09 1.62 0.45 0.09 1.76
EPS in Rs 10.00 0.00 720.00 0.80 1.19 0.33 0.04 0.71
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 5%
3 Years: -11%
TTM: 24747%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -56%
TTM: 242%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -42%
1 Year: 0%
Return on Equity
10 Years: %
5 Years: 4%
3 Years: 3%
Last Year: 0%

Balance Sheet

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 0.01 0.01 0.01 13.60 13.60 13.60 24.90 24.90
Reserves 0.01 0.01 0.73 9.57 11.19 11.64 19.64 19.69
0.00 0.01 0.00 8.16 9.58 4.24 0.00 0.00
2.12 5.62 7.30 2.00 0.53 7.39 5.47 7.63
Total Liabilities 2.14 5.65 8.04 33.33 34.90 36.87 50.01 52.22
0.00 0.00 0.00 0.00 0.01 0.01 0.22 0.20
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
2.14 5.65 8.04 33.33 34.89 36.86 49.79 52.02
Total Assets 2.14 5.65 8.04 33.33 34.90 36.87 50.01 52.22

Cash Flows

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.01 -0.02 0.03 -26.43 -4.35 5.32 -14.62
0.00 0.00 0.00 0.00 -0.01 -0.01 -0.26
0.00 0.00 0.00 29.49 1.42 -5.34 14.97
Net Cash Flow 0.01 -0.02 0.03 3.06 -2.94 -0.03 0.09
Free Cash Flow 0.01 -0.02 0.03 -26.43 -4.36 5.31 -14.88
CFO/OP 50% 3% -1,785% 99% -334% 654%

Ratios

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 138.14 189.94 249.16 552.50 308.25 156.81 267.54
Inventory Days 3.39 2.42 6.97 20.66 38.33 732.34 61.90
Days Payable 239.57 226.66 315.25 32.05 -10.20 767.44 97.59
Cash Conversion Cycle -98.04 -34.30 -59.11 541.11 356.78 121.72 231.85
Working Capital Days 1.12 1.21 26.23 436.56 440.90 2,263.00 1,369.06
ROCE % 0.00% 246.75% 9.11% 6.97% 1.91% 0.35%

Insights

In beta
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Advance from Customers
Rs. Lakhs

Log in to view insights

Please log in to see hidden values.

Login
Inventory (Stock-in-Hand)
Rs. Lakhs
Purchases of Stock-in-Trade
Rs. Lakhs
Sales Commission Income
Rs. Lakhs
Trade Receivables
Rs. Lakhs
Export Order Secured
Rs. Crores

Shareholding Pattern

Numbers in percentages

Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Sep 2025
73.53% 73.53% 73.53% 73.53% 20.53% 11.21% 11.21% 11.21% 11.21%
26.47% 26.48% 26.47% 26.47% 79.47% 88.79% 88.79% 88.78% 88.79%
No. of Shareholders 8247277077271,6721,5881,5771,7231,679

Documents

Announcements

Annual reports